The drugmaker said it will sell remdesivir for $390 per vial to governments “of developed countries” around the world, and the price for U.S. priv

Gilead’s coronavirus treatment remdesivir to cost $3,120 for U.S. insured patients

submited by
Style Pass
2020-06-29 13:48:54

The drugmaker said it will sell remdesivir for $390 per vial to governments “of developed countries” around the world, and the price for U.S. private insurance companies will stand at $520 per vial. In the U.S., that means Gilead will charge a lower price for government programs like Medicare and a higher price for privately insured people.

Leave a Comment